Interleukin-6 upregulates glucocorticoid receptor numbers in human osteoblast-like cells R.G. MaseraA. DovioA. Angeli OriginalPaper 26 April 2014 Pages: 103 - 107
Replacement therapy with DHEA plus corticosteroids in patients with chronic inflammatory diseases – substitutes of adrenal and sex hormones R.H. StraubJ. SchölmerichB. Zietz OriginalPaper 26 April 2014 Pages: 108 - 118
Mechanisms and clinical relevance of nongenomic glucocorticoid actions F. Buttgereit OriginalPaper 26 April 2014 Pages: 119 - 123
Is there immune dysregulation in symptomatic Gulf War veterans? M.P. EversonK. ShiW.D. Blackburn jr. OriginalPaper 26 April 2014 Pages: 124 - 126
What is low-dose corticosteroid therapy in juvenile idiopathic arthritis? H. Michels OriginalPaper 26 April 2014 Pages: 127 - 130
Dynamic thermography of the knee joints in rheumatoid arthritis (RA) in the course of the first therapy of the patient with methylprednisolone D. RuschM. FollmannG. Neeck OriginalPaper 26 April 2014 Pages: 131 - 135
Adrenal secretion of cortisol in patients with short-lasting rheumatoid arthritis B. Josipovic OriginalPaper 26 April 2014 Pages: 136 - 136
Bone mineral density and biochemical markers of bone metabolism in late onset rheumatoid arthritis and polymyalgia rheumatica – a prospective study on the influence of glucocorticoid therapy U. LangeB. BossG. Neeck OriginalPaper 26 April 2014 Pages: 137 - 141
Role of glucocorticoids on T cell recruitment across the blood-brain barrier B. Engelhardt OriginalPaper 26 April 2014 Pages: II18 - II21
New mode of hypothalamic-pituitary-adrenocortical axis regulation: significance for stress-related disorders J.M.H.M. ReulA. Bilang-BleuelA. Gesing OriginalPaper 26 April 2014 Pages: II22 - II25
The cytokine-HPA axis feed-back circuit H.O. BesedovskyA. del Rey OriginalPaper 26 April 2014 Pages: II26 - II30
The cytokine-HPA axis circuit contributes to prevent or moderate autoimmune processes A. del ReyH.O. Besedovsky OriginalPaper 26 April 2014 Pages: II31 - II35
Role of nitric oxide in the control of the hypothalamic-pituitary-adrenocortical axis W. Riedel OriginalPaper 26 April 2014 Pages: II36 - II42
Mechanisms of changes in lymphocyte numbers after psychological stress J. HennigP. NetterK. Voigt OriginalPaper 26 April 2014 Pages: II43 - II48
The dialogue between the brain and immune system involves not only the HPA-axis K. SchauensteinI. RinnerD.A. Chambers OriginalPaper 26 April 2014 Pages: II49 - II53
Adrenal androgen and glucocorticoid dissociation in premenopausal rheumatoid arthritis: a significant correlate or precursor to onset? A.T. MasiJ.C. AldagA.E. Kitabchi OriginalPaper 26 April 2014 Pages: II54 - II61
Correlation of IL-6 with the classical humoral disease activity parameters ESR and CRP and with serum cortisol, reflecting the activity of the HPA axis in active rheumatoid arthritis B. BossG. Neeck OriginalPaper 26 April 2014 Pages: II62 - II64
The hypothalamic-pituitary-adrenocortical and gonadal axis function in rheumatoid arthritis M. CutoloM. GiustiA. Sulli OriginalPaper 26 April 2014 Pages: II65 - II69
Glucocorticosteroids in pregnant patients with rheumatoid arthritis M. Østensen OriginalPaper 26 April 2014 Pages: II70 - II74
Relationship between interleukin-6 (IL-6) and hypothalamic-pituitary-adrenal axis hormones in rheumatoid arthritis G. MastorakosI. Ilias OriginalPaper 26 April 2014 Pages: II75 - II79
Prolactin levels and autoantibodies in female patients with systemic lupus erythematosus D. KozákováJ. RovenskýM. Vigaš OriginalPaper 26 April 2014 Pages: II80 - II84
Effects of long-term glucocorticoid therapy in rheumatoid arthritis J.R. Kirwan OriginalPaper 26 April 2014 Pages: II85 - II89
Low dose prednisolone therapy (LDPT) retards radiographically detectable destruction in early rheumatoid arthritis – R. RauS. Wassenbergfor the LDPT-Study Group OriginalPaper 26 April 2014 Pages: II90 - II96
Preventing glucocorticoid-induced osteoporosis I.R. Reid OriginalPaper 26 April 2014 Pages: II97 - II102
Replacement therapy with DHEA plus corticosteroids in patients with chronic inflammatory diseases - substitutes of adrenal and sex hormones R. H. StraubJ. SchölmerichB. Zietz OriginalPaper 26 April 2014 Pages: II108 - II118
What is low-dose corticosteroid therapy in juvenile idiopathic arthritis? Hartmut Michels OriginalPaper 26 April 2014 Pages: II127 - II130
Bone mineral density and biochemical markers of bone metabolism in late onset rheumatoid arthritis and polymyalgia rheumatica - a prospective study on the influence of glucocorticoid therapy U. LangeB. BossG. Neeck OriginalPaper 26 April 2014 Pages: II137 - II141
The 1st, 2nd ... and 3rd Bad Nauheim Conference on Rheumatology G. NeeckW. Riedel PREFACE 26 April 2014 Pages: IX - XI
Rheumatology: Challenges for the millenium J. Dequeker STATE OF THE ART 26 April 2014 Pages: XIV - XVIII
Molecular genetic dissection of glucocorticoid receptor function in vivo H.M. ReichardtJ.P. TuckermannG. Schütz OriginalPaper 26 April 2014 Pages: S1 - S5
Distinct proteins interacting with the glucocorticoid receptor M. SchulzR. ZhangR. Renkawitz OriginalPaper 26 April 2014 Pages: S6 - S11
Basic and clinical aspects of intraadrenal regulation of steroidogenesis S.R. BornsteinM. Ehrhart-Bornstein Pages: II12 - II17
